A prospective, multicenter, randomized controlled clinical trial evaluating the safety and efficacy of the Ruisheng medical antithrombotic cerebral protection device in capturing and removing thrombus/tissue debris during transcatheter aortic valve replacement.

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 712a8dda28c9e8b35b04b83b7e1b62714f86586d
First added on: Apr 24, 2026